SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001104659-22-099755
Filing Date
2022-09-14
Accepted
2022-09-13 18:14:45
Documents
16
Period of Report
2022-09-12
Items
Item 1.01: Entry into a Material Definitive Agreement
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 FORM 8-K tm2225658d1_8k.htm   iXBRL 8-K 55446
2 EXHIBIT 2.1 tm2225658d1_ex2-1.htm EX-2.1 44928
3 EXHIBIT 10.1 tm2225658d1_ex10-1.htm EX-10.1 40776
4 EXHIBIT 10.2 tm2225658d1_ex10-2.htm EX-10.2 51796
5 EXHIBIT 10.3 tm2225658d1_ex10-3.htm EX-10.3 22068
  Complete submission text file 0001104659-22-099755.txt   433635

Data Files

Seq Description Document Type Size
6 XBRL TAXONOMY EXTENSION SCHEMA srne-20220912.xsd EX-101.SCH 3069
7 XBRL TAXONOMY EXTENSION LABEL LINKBASE srne-20220912_lab.xml EX-101.LAB 34476
8 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE srne-20220912_pre.xml EX-101.PRE 22619
10 EXTRACTED XBRL INSTANCE DOCUMENT tm2225658d1_8k_htm.xml XML 3485
Mailing Address 4955 DIRECTORS PLACE SAN DIEGO CA 92121
Business Address 4955 DIRECTORS PLACE SAN DIEGO CA 92121 858-203-4100
Sorrento Therapeutics, Inc. (Filer) CIK: 0000850261 (see all company filings)

IRS No.: 330344842 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-36150 | Film No.: 221241711
SIC: 2836 Biological Products, (No Diagnostic Substances)